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HCMV is a highly sophisticated virus that has devel-
oped various mechanisms for immune evasion and
viral dissemination throughout the body (partially
mediated by neutrophils). NK cells play an important
role in elimination of HCMV-infected cells. Both neu-
trophils and NK cells utilize similar sets of chemokine
receptors to traffic, to and from, various organs.
However, the mechanisms by which HCMV attracts
neutrophils and not NK cells are largely unknown.
Here, we show a unique viral protein, vCXCL1, which
targets three chemokine receptors: CXCR1 and
CXCR2 expressed on neutrophils and CXCR1 and
CX3CR1 expressed on NK cells. Although vCXCL1
attracted both cell types, neutrophils migrated faster
and more efficiently than NK cells through the bind-
ing of CXCR2. Therefore, we propose that HCMV
has developed vCXCL1 to orchestrate its rapid sys-
temic dissemination through preferential attraction
of neutrophils and uses alternative mechanisms to
counteract the later attraction of NK cells.
INTRODUCTION
Human cytomegalovirus (HCMV) belongs to the beta herpes-
virus subfamily (Jain et al., 2011; Stern-Ginossar et al., 2012).
Following primary infection, HCMV establishes latent infection,
similarly to other members of the herpesvirus family (Goodrum
et al., 2012; Slobedman et al., 2010). Occasionally, HCMV can
undergo re-activation and initiate productive infection in which
new infectious progeny are produced. HCMV infection is mostly
asymptomatic in immune-competent individuals, whereas in
immune-compromised individuals (such as transplant recipi-
ents) or in congenitally infectedneonates, it cancausesubstantial
morbidity and mortality (Griffiths, 2012; Slobedman et al., 2010).1542 Cell Reports 15, 1542–1553, May 17, 2016 ª 2016 The Author(s
This is an open access article under the CC BY-NC-ND license (http://Likeother virusesof theherpesvirus family,HCMVhasdeveloped
various sophisticatedmechanisms to evade the innate andadap-
tive immune responses (Jackson et al., 2011). In particular,
HCMV has developed several mechanisms to evade and subvert
the activity of natural killer (NK) cells (Brizic et al., 2014; Fielding
et al., 2014; Halenius et al., 2015; Lisnic et al., 2015; Seidel
et al., 2015; Slavuljica et al., 2011; Stern-Ginossar et al., 2007;
Wilkinson et al., 2008).
NK cells belong to the innate immune system (Fehniger et al.,
2003) and are best known for their important role in controlling
tumor development and viral infections (Cheent and Khakoo,
2009; Cooper et al., 2001). Mature NK cells in the blood can be
divided into two subpopulations based on the expression of
CD56 and CD16. The CD56Dim NK cells express intermediate
levels of the CD56 adhesion molecule, express CD16, and
constitute around 90% of the NK cells, whereas CD56Bright NK
cells that express high levels of CD56 lack the CD16 receptor
and constitute approximately 10% of the peripheral blood NK
cells (Cooper et al., 2001; Fehniger et al., 2003). These two NK
cell populations are also functionally distinct: CD56Dim CD16Pos
NK cells are highly cytotoxic, whereas the CD56Bright CD16Neg
NK cells are poorly cytotoxic and aremainly responsible for cyto-
kine secretion (Cooper et al., 2001).
Both NK cell populations express adhesion molecules and
chemokine receptors that enable them to circulate in the blood
and migrate into secondary lymphoid organs or inflamed tissues
(Carrega and Ferlazzo, 2012; Hanna et al., 2003; Santoni et al.,
2007).There is inconsistency in the literature regarding thechemo-
kine receptor expression profile on the cell surface of the two
NK cell populations. To our knowledge, most publications agree
that freshly isolatedCD56DimCD16PosNKcells express high levels
of CXCR1 and CX3CR1; low levels of CXCR2, CXCR4, and CCR5
(which might differ between donors); and no detectable levels of
CCR1–4 or CCR6 (Berahovich et al., 2006; Hanna et al., 2003; In-
ngjerdingen et al., 2001; Morohashi et al., 1995; Robertson, 2002;
Yoneda et al., 2000). Hence, this NK population migrates mainly
toward fractalkine (Fck/CX3CL1; CX3CR1 ligand), stromal-cell-
derived factor 1 alpha (SDF1a/CXCL12; CXCR4 ligand), and)
creativecommons.org/licenses/by-nc-nd/4.0/).
interleukin-8 (IL-8) (CXCL8; CXCR1 ligand). In contrast, CD56Bright
CD16Neg NK cells express mostly CCR5, CCR7, and CXCR3
and low levels of CXCR4 and CX3CR1 and do not express
CCR1–4, CCR6, CXCR1, or CXCR2 (Campbell et al., 2001; Hanna
et al., 2003). Migration of this NK cell subtype is mostly stimu-
lated by CXCL10 and CXCL11 (CXCR3 ligands), SDF1a (CXCR4
ligand), and CCL19 and CCL21 (CCR7 ligands; Campbell et al.,
2001; Hanna et al., 2003; Morohashi et al., 1995; Yoneda et al.,
2000).
Emerging evidence has demonstrated that NK cells cross-talk
with other immune cell types such as neutrophils, which also
belong to the innate immune system (Scapini and Cassatella,
2014). Neutrophils are polymorphonuclear leukocytes and are
the first leukocytes to appear on site during the initiation of an in-
flammatory process. CXCR1, CXCR2, and CXCR4 are the main
chemokine receptors expressed by human neutrophils (Eash
et al., 2009; Kolaczkowska and Kubes, 2013; Petering et al.,
1999). SDF1a expression by stromal cells is responsible for the
retention signal that keeps the neutrophils in the bone marrow
(Eash et al., 2009, 2010). IL-8 (CXCR1 and CXCR2 ligand), on
the other hand, is involved in recruitment and activation of neu-
trophils during inflammation (Hammond et al., 1995).
HCMV has developed several mechanisms to avoid innate
immune cell attack, one of which is viral mimicry of chemokines
(Alcami, 2003; McSharry et al., 2012). HCMV encodes one gene,
UL128, which exhibits sequence similarity to CC chemokines.
UL128 participates in HCMV entry into endothelial and epithelial
cells and promotes proliferation of peripheral blood mono-
nuclear cells (PBMCs) by activating the MAPK/ERK (mitogen-
activated protein kinase/extracellular-signal-regulated kinase)-
signaling pathway (Zheng et al., 2012). In addition, HCMV
encodes two genes, UL146 and UL147, with sequence similarity
to CXC chemokines (Penfold et al., 1999). Previous papers
showed that viral CXC-ligand 1 (vCXCL1; UL146 gene product)
induces calcium mobilization and chemotaxis of human neutro-
phils. However, contradicting results were obtained regarding
the identity of the receptors participating in the neutrophil migra-
tion by vCXCL1. Some papers show that the migration is medi-
ated by both CXCR1 and CXCR2, whereas others claim that
CXCR2 alone is responsible for neutrophil migration through
vCXCL1 (Heo et al., 2015; L€uttichau, 2010; Penfold et al.,
1999). Although vCXCL2 (UL147 gene product) was discovered
to be a CXC chemokine quite some time ago, little is known
about its function or ability to bind to chemokine receptors on
human immune cells (Penfold et al., 1999).
In our previous paper, we demonstrated that Kaposi’s
sarcoma-associated herpesvirus (KSHV) encodes a viral chemo-
kine, vMIP-II, which binds freshly isolated CD56Dim CD16Pos NK
cells via CX3CR1 and IL-2-activated NK cells through CCR5.
Furthermore, we showed that this binding inhibits NK cell migra-
tion in vitro (Yamin et al., 2013). Because HCMV is known to be a
master of immune evasion, wewanted to investigate whether the
HCMV-derived viral chemokines will also have a similar effect on
NK cells. Here, we show that vCXCL1, one of the viral chemo-
kines encoded by HCMV, functions as an agonist and induces
NK cell and neutrophil migration. We demonstrated that vCXCL1
binds CX3CR1. We show that neutrophils migrated faster and
more efficiently than NK cells, and we propose that HCMV hasdeveloped vCXCL1 to orchestrate its rapid systemic dissemina-
tion through preferential attraction of neutrophils and uses alter-
native mechanisms to counteract the later secondary attraction
of NK cells.
RESULTS
vCXCL1-Ig Binds CD56Dim CD16Pos Naive NK Cells
To test whether vCXCL1 interacts with NK cells, we cloned it
from cDNA derived from urine of a congenitally infected newborn
(most resemble the Merlin HCMV strain; Figure S1; Experimental
Procedures) and fused it to the Fc domain of human immuno-
globulin G1 (IgG1). The construct was stably expressed in
293T cells, and the corresponding protein was purified using a
protein G column and used to stain freshly isolated NK cells or
IL-2-activated NK cells. As shown in Figure 1, vCXCL1-Ig binds
CD56Dim CD16Pos naive NK cells (Figure 1A, red circles; figure
shows vCXCL1 staining relative to CD56 only), but not the
CD56Bright CD16Neg NK cell population (Figure 1A, black circles;
staining of several donors is summarized in Figure 1B). IL-2-acti-
vated NK cells were not recognized by vCXCL1-Ig (Figure 1C;
staining of several donors is summarized in Figure 1D). No stain-
ing was detected when a control-Ig protein was used (Figure 1).
CD56Dim CD16Pos NK Cells Mainly Express Two
Chemokine Receptors: CXCR1 and CX3CR1
There are mixed reports regarding the precise identity of the
chemokine receptors that interact with vCXCL1 (L€uttichau,
2010; Penfold et al., 1999). To determine the identity of the che-
mokine receptor(s) expressed on NK cells, which may interact
with vCXCL1, we initially tested which chemokine receptors
are expressed on theCD56Dim CD16Pos NK cells by double stain-
ing of freshly isolated NK cells with anti-CD56 in tandem with
anti-CCR1, CCR2, CCR3, CCR5, CXCR1, CXCR2, CXCR4, or
CX3CR1 monoclonal antibodies (mAbs). As can be seen in Fig-
ure 2A and summarized in Table S1A, CXCR1 and CX3CR1
were the only receptors exhibiting expression patterns similar
to that of vCXCL1-Ig staining of freshly isolated NK cells
(compare Figures 2A and 1A). Both CXCR1 and CX3CR1 were
expressed on the entire CD56Dim CD16Pos, but not on the
CD56Bright CD16Neg, NK cell population and were completely
downregulated following NK cell activation (Figure 2B; Table
S1C). Other chemokine receptors that we tested showed low
or no expression on the CD56Dim CD16Pos NK cell population
(Figure 2A; Table S1). The expression of two other receptors,
CCR5 and CXCR4, were donor-dependent (Table S1B). Thus,
we considered the possibility that CXCR1 and CX3CR1 might
interact with vCXCL1 on naive NK cells.
rvCXCL1 InducesMigration of Naive NKCells via CXCR1
and CX3CR1
We have previously demonstrated that the KSHV-encoded che-
mokine vMIP-II blocks NK cell migration (Yamin et al., 2013). To
investigate whether vCXCL1 also antagonizes the migration of
NK cells, we performed transwell migration assay in the pres-
ence of increasing concentrations of recombinant vCXCL1
(rvCXCL1), derived from a Toledo strain (Figure S1). Surprisingly,
and in contrast to what we observed with the KSHV-derivedCell Reports 15, 1542–1553, May 17, 2016 1543
Figure 1. vCXCL1-Ig Binds CD56Dim CD16Pos Naive NK Cells
(A and C) Dot plot FACS staining of freshly isolated naive NK cells (A) and IL-2-activated NK cells (C) stained with vCXCL1-Ig or with control-Ig together with anti-
CD56. The percentages of various populations are indicated inside the dot plots. Figure shows one representative staining out of more than four performed.
(B and D) Summary data of inter-donor variability in vCXCL1-Ig binding to naive NK cells (B) or IL-2-activated NK cells (D). Table shows both mean fluorescence
intensity (MFI) and the percentage of the positive cells.vMIP-II chemokine (Yamin et al., 2013), a significant, dose-
dependent migration of NK cells was detected toward rvCXCL1
(Figure 3A). The migration efficiency was similar to NK cell
migration toward rhFck and rhIL8; both are well-known chemo-
attractants of NK cells (Figure 3A) and could be blocked by
usage of neutralizing monoclonal antibody against vCXCL1
(Figure 3B). Thus, we concluded that vCXCL1 interacts with
the naive CD56Dim CD16Pos NK cell population, possibly via
CXCR1, CX3CR1, or both, and that this interaction probably
leads to NK cell migration.
It is well established that binding of chemokines to their re-
ceptors can cause rapid internalization of the receptor due to
agonist-dependent phosphorylation of the C-terminal tail of the
G protein-coupled receptor (Allen et al., 2007; Neel et al., 2005).
Therefore, chemokine receptor internalization is used as readout
for interaction with an appropriate ligand (Allen et al., 2007; Neel
et al., 2005). To investigate the ability of vCXCL1 to bind CXCR1
and CX3CR1 on NK cells, we performed internalization assays
in which we incubated freshly isolated NK cells with two doses
(0.1 mg or 1 mg) of rvCXCL1 and then stained them with anti-
CX3CR1 or anti-CXCR1 (Figure 4A; summarized in Table S2).
For controls, we used recombinant human IL-8 and fractalkine
(rhIL8 and rhFck, the natural ligands of CXCR1 and CX3CR1,
respectively). IncubationofNKcellswith1mgof rvCXCL1 resulted
in a downregulation of both CX3CR1 and CXCR1 (Figure 4A,
green histograms), indicating that vCXCL1 interacts with both re-
ceptors. The vCXCL1-mediated internalization was significant
(25% and40% reduction in CX3CR1 and CXCR1 cell surface
expression, respectively) and repeated with similar outcome be-
tween the different donors (Table S2). Incubation of rhFck with
NK cells led to a complete downregulation of CX3CR1, but not1544 Cell Reports 15, 1542–1553, May 17, 2016CXCR1 (Figure 4A, blue histograms; summarized in Table S2),
whereas incubation of rhIL8 resulted in a complete downregula-
tion of CXCR1, but not CX3CR1 (Figure 4A, red histograms; sum-
marized in TableS2). The downregulation ofCX3CR1andCXCR1
by their corresponding natural ligands was complete and
observed using a low quantity (0.1 mg) of the appropriate chemo-
kines (Figure 4A; summarized in Table S2). Thus, we concluded
that vCXCL1 interacts directly with CX3CR1 and CXCR1 and
that these interactions are probably of low affinity.
Itwaspreviously shown that vCXCL1 interactswithCXCR1,but
not with CX3CR1 (L€uttichau, 2010). Thus, to further demonstrate
that vCXCL1directly interactswithCX3CR1,westably expressed
CX3CR1 in 293T cells and used these 293T-CX3CR1-trans-
fected cells to assay for vCXCL1-Ig binding. As can be seen,
we observed that vCXCL1-Ig binds preferentially to the 293T-
CX3CR1 transfectant cells (black empty histogram) as compared
to 293T parental cells (gray empty histogram; Figure 4B).
To further demonstrate that vCXCL1 directly interacts with
CX3CR1 and CXCR1 and that this interaction is functional,
we conducted transwell migration assays. In these assays, we
pre-incubated freshly isolated NK cells with rvCXCL1, rhFck, or
rhIL8 and then tested the cells’ migration toward rvCXCL1. As
shown in Figure 4C, rvCXCL1 caused NK cell migration and this
migration was inhibited by around 40% when NK cells were
pre-incubated with rvCXCL1, rhFck, or rhIL8. When the NK cells
were pre-incubated with both rhFck and rhIL8, approximately
80% inhibition ofmigrationwas observed. The chemokine-medi-
ated inhibition of migration was specific because no effect was
detected when recombinant human chemerin (rhChemerin;
ChemR23 ligand) was used. Thus, vCXCL1 binds CX3CR1 and
CXCR1 on NK cells and attracts NK cells.
Figure 2. CD56Dim CD16Pos Naive NK Cells Mainly Express Two Chemokine Receptors: CXCR1 and CX3CR1
(AandB)DotplotFACSstainingof freshly isolatednaiveNKcells (A)and IL-2-activatedNKcells (B)doublestainedwithanti-CD56mAbtogetherwithspecificantibodies
against each of the following chemokine receptors: CCR1; CCR2; CCR3; CCR5; CXCR1; CXCR2; CXCR4; andCX3CR1 (indicated on the x axes). The percentages of
various populations are indicated inside the dot plots. Figure shows one representative staining out ofmore than four performed for each receptor. See also Table S1.rvCXCL1 Induces Migration of Neutrophils via CXCR1
and CXCR2
HCMV is known to be a master of immune evasion. In particular,
it developed many mechanisms to interfere with NK cell activity(Fielding et al., 2014; Seidel et al., 2015; Slavuljica et al.,
2011; Stern-Ginossar et al., 2007; Wilkinson et al., 2008). These
observations together with the results presented here, in which
the binding of vCXCL1 to CX3CR1 and CXCR1 on NK cells isCell Reports 15, 1542–1553, May 17, 2016 1545
Figure 3. RvCXCL1 Induces Migration of Naive NK Cells
(A) Transwell migration assays of freshly isolated NK cells toward increasing
concentrations of rvCXCL1 (indicated on the x axis). RhFck and rhIL8 were
used as positive controls. Percent of migrating cells was calculated out of total
input cells. Data are presented as mean ± SEM (n = 4).
(B) Freshly isolated NK cells were incubated for 1 hr with mAb against vCXCL1
or isotype-matched control. RvCXCL1 was placed in the bottom chamber, and
migration was performed for 3 hr at 37C. The numbers of migrated cells was
determined by FACS following 3 hr of incubation at 37C. The basal migration
rate of NK cells toward medium that did not contain rvCXCL1 was set as 1 and
the results presented as fold increase (FI). *p < 0.05. **p < 0.005.inefficient, prompted the hypothesis that vCXCL1 is used by the
virus for additional purposes. It was previously speculated that
vCXCL1 might attract neutrophils through CXCR2 to enable its
spread throughout the body (L€uttichau, 2010). To test this, we
isolated peripheral blood neutrophils (Figure 5A, red rectangle)
and stained them with chemokine receptors previously shown
to interact with vCXCL1: CXCR1; CXCR2 (L€uttichau, 2010;
Penfold et al., 1999); and CX3CR1. As can be seen in Figure 5A
(summarized in Table S3A), neutrophils express CXCR1 and
CXCR2, but not CX3CR1. Next, we tested whether vCXCL1
attracts neutrophils, similarly to NK cells, and observed that neu-
trophils indeed migrated toward rhIL8 and rvCXCL1 (Figure 5B).
No migration was detected toward rhFck (Figure 5B), as they do
not express its receptor, CX3CR1 (Figure 5A). Neutrophil migra-
tion toward 100 ng/ml rvCXCL1 was more efficient compared to
NK cell migration at the same concentration (note the difference
in migration percentages between Figures 3A and 5B).
To demonstrate that vCXCL1 binds CXCR1 and CXCR2 on
neutrophils, we performed internalization assays in which we
pre-incubated peripheral blood neutrophils together with either
rhIL8 (Figure 5C, red histograms; Table S3B) or rvCXCL1 (Fig-
ure 5C, green histograms; Table S3B). Two different quantities
(0.1 mg or 1 mg) of chemokines were used, and we subsequently
stained the neutrophils with either anti-CXCR1 or anti-CXCR2
mAbs. RhIL8 caused CXCR1 downregulation when using
0.1 mg, and this downregulation was further enhanced when us-
ing 1 mg of rhIL8 (Figure 5C, red histograms; Table S3B). CXCR2
was also downregulated following pre-incubation with rhIL8
(Figure 5C, red histograms). In agreement with what was
shown in the NK cells (Figure 4A), pre-incubation of neutrophils
with 0.1 mg rvCXCL1 had no effect on the expression levels of
CXCR1, but when 1 mg was used, a modest downregulation of
CXCR1 was observed (Figure 5C, green histograms; Table1546 Cell Reports 15, 1542–1553, May 17, 2016S3B). Interestingly, a pronounced downregulation (75% reduc-
tion; Table S3B) of CXCR2 was observed even when neutrophils
were incubated with only 0.1 mg of rvCXCL1 (Figure 5C, green
histograms). Thus, we conclude that, of the three vCXCL1-
binding chemokine receptors: CXCR2; CX3CR1; and CXCR1,
vCXCL1 binds most efficiently to CXCR2.
To test whether vCXCL1 attracts neutrophils via CXCR1 and
CXCR2, we performed a migration assay in which we pre-incu-
bated the neutrophils with rhFck, rhIL8, or rvCXCL1 and then
tested their migration toward rvCXCL1. Pre-incubation with
rhFck showed no effect on neutrophil migration and was there-
fore set as 100% (Figure 5D). In contrast, pre-incubation of
neutrophils either with rhIL8 or rvCXCL1 prevented neutrophil
migration toward rvCXCL1 (Figure 5D).
Neutrophils React Faster and More Efficiently to
rvCXCL1 in Comparison to NK Cells
As rvCXCL1 seemed to bind CXCR2with the highest affinity, and
because neutrophil migration toward vCXCL1 wasmore efficient
as compared to that of NK cells, we speculated that vCXCL1 at-
tracts neutrophils faster than NK cells. To test this hypothesis,
we simultaneously tested the migration kinetics of neutrophils
and NK cells derived from the same donor toward rvCXCL1,
rhIL8, or rhFck. As can be seen, neutrophils indeed migrated
faster and more efficiently than NK cells toward rvCXCL1 and
rhIL8 (Figure 6A). In contrast, neutrophils did not migrate toward
rhFck (as they do not express CX3CR1), whereas NK cells did
(Figure 6A). To further assess the preferential migration of neu-
trophils over NK cells toward rvCXCL1, we mixed neutrophils
and NK cells together in the upper chamber of a transwell (Fig-
ure 6B) and examined their migration toward rvCXCL1, following
30 min and 3 hr. As can be seen in Figure 6C, 40% of the neutro-
phils, which were placed in the upper chamber together with NK
cells, migrated toward rvCXCL1 after 30 min, whereas at this
time point, little or no NK cell migration was observed (Figure 6C,
left panel). Following 3 hr of co-incubation, NK cell migration
toward rvCXCL1 was detected (Figure 6C, black columns, right
panel); however, the neutrophil migration was much more
pronounced (Figure 6C, gray columns, right panel). Thus, the
neutrophil migration in response to vCXCL1 is faster and more
efficient.
vCXCL1 Secretion following HCMV Infection Primarily
Attracts Neutrophils
Finally, we wanted to test whether vCXCL1 secreted during
HCMV infection will attract neutrophils and NK cells. We initially
wanted to determine the vCXCL1 concentration present in the
supernatants of the infected cells. Unfortunately, the mAb that
recognized vCXCL1 that was developed against the vCXCL1
Toledo strain was unable to recognize the vCXCL1 of the
AD169 strain (probably because vCXCL1 is a highly polymorphic
protein and substantially different between AD169 and Toledo
strains; Figure S1). Therefore, to determine the concentration
of vCXCL1 in the supernatant of the infected cells, we developed
a calibration assay (described in detail in the Experimental Pro-
cedures section) that is based on CXCR2 internalization. The
estimated vCXCL1 concentration in the supernatant was more
than 150 ng/ml (blue square, Figure 7A), a concentration that is
Figure 4. RvCXCL1 Induces Naive NK Cell Migration via CX3CR1 and CXCR1
(A) Freshly isolated NK cells were incubated with and without 0.1 mg and 1 mg (indicated on the left side of the figure) of rhIL8 (red histograms, left), rhFck (blue
histograms, middle), or rvCXCL1 (green histograms, right), at 37C for 1 hr. Next, cells were stained with anti-CX3CR1 (two upper rows) or with anti-CXCR1 (two
lower rows). Open gray histograms show the staining of the chemokine receptors on untreated cells. Filled gray histograms show staining of the untreated NK
cells with an isotype control. The backgrounds of the treated cells were similar to the untreated cells and are not shown in the figure. See also Table S2.
(B) Binding of vCXCL1-Ig to 293T-CX3CR1 transfectant (black open histogram) or to the 293T parental cells (gray open histogram). Filled gray histogram is the
staining of the control fusion protein (control-Ig) on the 293T-CX3CR1-transfected cells. Staining of the parental 293T cells with control-Ig was similar to the 293T-
CX3CR1-transfected cells and is not shown in the figure.
(C) Freshly isolated NK cells were incubated for 1 hr with and without the proteins indicated on the x axis. RvCXCL1 was placed in the bottom chamber, and
migration was performed for 3 hr at 37C. Migrating cells were counted by FACS. NK cell migration toward rvCXCL1 without pre-blocking was set as 100%, and
the results are presented as % of migration. *p < 0.05. NS, not significant. Figure shows one representative experiment out of three performed.sufficient to induce NK cell (Figure 3A) and neutrophil migration
(Figure 5B).
To test whether vCXCL1 is responsible for the NK cell and
neutrophil migration, we generated an HCMV deletion mutant
lacking UL146 (HCMV DUL146) on AD169 VarL strain back-
ground. We verified that the mutant growth kinetics following
infection was similar to that of the wild-type virus (Figure 7B).
Next, we infected human foreskin fibroblast (HFF) either with
the wild-type (WT) HCMV strain or with HCMV DUL146 at a MOI
of 1; supernatants from the infected cells were collected 72 hr
postinfection, because it was previously published that vUL146
is expressed late in the virus life cycle (Penfold et al., 1999).
Migration assays were performed in parallel with freshly isolated
neutrophils and NK cells toward supernatants collected from
mock-infected, WT HCMV-infected, or HCMV DUL146-infected
cells. Both neutrophils and NK cells migrated toward superna-
tantsobtained fromWTHCMV-infectedcells; however, neutrophilmigration was strongly induced compared to NK cell migration
(Figures 7Cand 7D). Importantly, in the absenceof vCXCL1 (using
supernatants from HCMV DUL146-infected cells), the neutrophil
migrationwasalmost completely abolished (Figure 7C), indicating
that, following HCMV infection, neutrophil migration is primarily
UL146 dependent. In contrast, only a modest (15%) but a statisti-
cally significant reduction inNKcell migrationwas observed in the
absence of vCXCL1 (Figure 7D).
To further strengthen these observations, we pre-incubated
neutrophils or NK cells with rvCXCL1 and with the key chemo-
kines that induce downregulation of the appropriate receptors
(rhIL8 in the case of neutrophils that leads to the downregulation
of CXCR1 and CXCR2 and a combination of rhFck and rhIL8
that leads to the downregulation of CXCR1 and CX3CR1, in
the case of NK cells). In agreement with what is shown with
supernatant from HCMV DUL146-infected cells, incubation of
neutrophils with rhIL8 completely abolished their migrationCell Reports 15, 1542–1553, May 17, 2016 1547
Figure 5. RvCXCL1 Induces Neutrophil Migration via CXCR1 and CXCR2
(A) Freshly isolated neutrophils were stained with mAb against CD16 and CEACAM1 (left dot plot). The double positive fraction (red square) was stained with
specific antibodies against the chemokine receptors CXCR1, CXCR2, and CX3CR1.
(B) Transwell migration assays were performed using freshly isolated neutrophils toward the recombinant proteins indicated on the x axis (rhFck, rhIL8, or
rvCXCL1). The number of migrating cells was quantified by FACS, following a 30-min incubation period, at 37C. Percent of migrating cells out of total input cells
was calculated. Data are presented as mean ± SEM (n = 6).
(C) Freshly isolated neutrophils were incubated with and without 0.1 mg and 1 mg (indicated in the left of the figure) of rhIL8 (red histograms, left) or rvCXCL1 (green
histograms, right) for 10 min at 37C, followed by staining with anti-CXCR1 (two upper rows) or anti-CXCR2 (two lower rows). Open gray histograms show
chemokine receptors staining of the untreated cells. Filled gray histograms represent staining of the untreated cells with an isotype control. The backgrounds of
the treated cells were similar to the untreated cells and are not shown in the figure.
(D) Freshly isolated neutrophils were incubated at 37C for 10 min with or without the proteins indicated on the x axis. RvCXCL1 was placed in the bottom
chamber, and the migrating neutrophils were counted using FACS following 30 min incubation at 37C. Neutrophil migration toward rvCXCL1 after pre-blocking
with rhFck was set as 100%, and the results are presented as % of migration. *p < 0.05. **p < 0.005. Figure shows one representative experiment out of three
performed.
See also Table S3.toward the supernatant from WT-HCMV-infected cells (Fig-
ure 7E). Incubation of NK cells with rhFck and rhIL8 together
led to a partial reduction in the migration (Figure 7F). Thus, we
concluded that, during HCMV infection, neutrophil migration is
dependent on UL146, whereas NK cell migration does not
depend exclusively on UL146 and might involve other receptors
beside CXCR1 and CX3CR1.1548 Cell Reports 15, 1542–1553, May 17, 2016DISCUSSION
Here, we show that HCMV-encoded vCXCL1 binds to NK
cells and not only to neutrophils. Furthermore, we discovered,
using three different assays (receptor internalization, direct
binding, and functional experiments) that CX3CR1 interacts
with vCXCL1. This result is in disagreement with a previous
Figure 6. Neutrophils Migrate Faster and More Efficiently Than NK Cells in Response to rvCXCL1
(A) A transwell migration assay was performed using rvCXCL1, rhIL8, or rhFck as the chemoattractant with either freshly isolated neutrophils (gray triangles) or NK
cells (black squares) placed in the upper chamber for 10, 20, and 30 min at 37C. Migration of untreated neutrophils and NK cells at the beginning of the
experiment was set as 1, and the results are presented as FI. Figure shows one representative experiment out of two performed.
(B) Diagram that describes competitive transwell migration assay in which NK cells and neutrophils were incubated together at the upper chamber and their ability
to migrate toward rvCXCL1 (lower chamber) is determined.
(C) Competitive transwell migration assays described in (B) was performed for 30 min (left panel) and 3 hr (right panel). Percent of migrating cells out of total input
cells was calculated separately for neutrophils (gray) and NK cells (black). Data are presented as mean ± SEM (n = 3). *p < 0.05. **p < 0.005. ***p < 0.0005.study, which demonstrated vCXCL1 binding only to CXCR1
and CXCR2, but not CX3CR1 (L€uttichau, 2010).
We show that vCXCL1 binds two chemokine receptors on
CD56Dim CD16Pos NK cells, CX3CR1 and CXCR1. Indeed, block-
ing of these two receptors by their natural ligands, Fck and IL-8
(respectively), abolished the migration of NK cells toward the
viral chemokine almost completely. Following cytokine stimula-
tion, NK cells become highly cytotoxic and the expression profile
of killer and chemokine receptors changes (Hamann et al., 2011;
Inngjerdingen et al., 2001; Sechler et al., 2004; Vitale et al., 1998).
Among these receptors are also CXCR1 and CX3CR1, which
disappear from the cell surface following IL-2 activation. There-
fore, it is not surprising that vCXCL1 does not bind IL-2-activated
NK cells.
Because vCXCL1 is a viral protein, the migration of NK cells
toward vCXCL1 was surprising and raises the question as to
why should the virus develop a viral chemokine to attract NK
cells that can potentially eliminate the virus. HCMV is highly
adapted to its human host and developed numerous mecha-
nisms in order to escape recognition by NK cells (Wilkinson
et al., 2008). For example, UL18, a viral MHC class I homolog
protein, is involved in these immune escape mechanisms
through efficient binding to the inhibitory receptor ILT2, leading
to reduced NK cell activity (Cosman et al., 1997; Prod’hommeet al., 2007). Another strategy to avoid NK cell recognition
is downregulation of the stress-induced ligands. UL16, for
example, binds the stress-induced ligands MICB, ULBP1, and
ULBP2 and sequesters them in the endoplasmic reticulum,
hampering NK activation (Welte et al., 2003). US9 is a viral glyco-
protein that targets a specific allele of MICA and illustrates the
co-evolution of HCMV with its human host (Seidel et al., 2015).
Furthermore, HCMV uses not only viral proteins but also viral en-
coded microRNAs (miRNAs). HCMV-miR-UL112, for instance,
downregulates the stress-induced ligand MICB during viral
infection and therefore leads to reduced killing of the infected
cells by NK cells (Stern-Ginossar et al., 2007). Thus, we assumed
the HCMV can deal with NK cells and that vCXCL1 is produced
by the virus for other purposes.
As previously shown, vCXCL1 does not only bind NK cells but
also neutrophils, via the chemokine receptors CXCR1 and
CXCR2 (Heo et al., 2015; L€uttichau, 2010). These two receptors
bind the same ligand, IL-8, and therefore, as we show here,
usage of rhIL8 alone was enough to abolish neutrophil migration
toward vCXCL1.
As binding of rvCXCL1 led to a partial internalization of
CXCR1 and to a significantly higher internalization of CXCR2,
we concluded that vCXCL1 binds CXCR2 with higher affinity
compared to CXCR1. This also explains why neutrophils migrateCell Reports 15, 1542–1553, May 17, 2016 1549
Figure 7. Reduced Neutrophil and NK Cell Migration in the Absence of UL146 during HCMV Infection
(A) Freshly isolated neutrophils were incubated with increasing concentrations (indicated in the x axis) of rvCXCL1 (gray circles) for 30 min at 37C, followed by
staining with anti-CXCR2. MFI of CXCR2 expression without blocking was set on 100%, and the residual CXCR2 expression was calculated. Estimated levels of
vCXCL1 following infection of HFF cells with WT HCMV are shown as blue square on the graph.
(B) HFFs were infected (MOI of 0.5) with WT HCMV (blue circles) or DUL146 (red circles), and supernatants containing progeny viruses were harvested at the
indicated hours postinfection (x axis). The plaque-forming units (PFU) were determined using a standard plaque assay on HFF monolayers.
(C and D) HFF cells were infected with WT HCMV or with HCMV DUL146 at a MOI of 1. Three days postinfection, cell supernatants were collected and used for
transwell migration assayswith either neutrophils (C) or NK cells (D). Neutrophils andNK cell migration toward supernatants frommock-infected HFFwas set as 1,
and the results are presented as FI.
(E and F) Freshly isolated neutrophils were incubated at 37C for 30 min with or without the proteins indicated on the x axis. Transwell migration assays were
performed with neutrophils (E) or NK cells (F) toward supernatant from mock-infected or WT-HCMV-infected HFFs. Neutrophils and NK cell migration toward
supernatants from mock-infected cells was set as 1, and the results are presented as FI. *p < 0.05. **p < 0.005. ***p < 0.0005.
(G) HCMV-infected endothelial cells secrete vCXCL1 (1) and recruit both neutrophils and NK cells to the infection site (2). Migration of NK cells is dependent on
CXCR1 and CX3CR1 receptors, whereas neutrophil migration is dependent on CXCR2 and CXCR1. Neutrophils migrate faster andmore efficiently in comparison
to NK cells due to their CXCR2 receptor (3). Therefore, neutrophils reach the infection site early and can disseminate the virus while proceeding to travel
throughout the body (4). This enables the virus to maintain a pool of HCMV-infected cells. NK cells that migrate toward vCXCL1 will get to the infection site at a
later time point (5) and will be subverted by HCMV-immune evasion tactics.toward vCXCL1 more efficiently in comparison to NK cells (fold
increase of 15 in neutrophils versus 2 in NK cells), as CXCR2 is
not expressed by NK cells. In that respect, neutrophils not
only migrate faster toward vCXCL1, but they also do it more
efficiently.
vCXCL1 is a highly polymorphic protein (Figure S1). In this
study, we used three variants of the protein: vCXCL1-Ig derived
from a Merlin strain; rvCXCL1 derived from a Toledo strain; and1550 Cell Reports 15, 1542–1553, May 17, 2016the native protein from the AD169VarL strain. It is interesting to
note that, although these strains share low percentage of identity
(Figure S1), they consistently showed the same binding patterns
and effects, both on neutrophils and on NK cells, indicating that,
despite sequence variations, the primary function of this protein
appears to be conserved.
During infection, vCXCL1 is expressed as a late protein in the
virus life cycle and is released from the infected cells. HCMV
deleted for the UL146 gene (which encodes vCXCL1) exhibits
low ability to induce migration of neutrophils. Unlike neutrophils,
NK cells still migrated in the absence of the UL146 gene,
although the migration was lower than in the presence of
UL146. This phenomenon might occur if NK cells are migrating
toward other factors and not only vCXCL1 followingHCMV infec-
tion. The identity of these factors is currently unknown, but we
hypothesize that these factors bind other receptors than
CXCR1 and CX3CR1, because blocking of these receptors
with rhFck and rhIL8 did not abrogate NK cell migration.
The fact that UL146 is a late gene might offer an additional
explanation to the apparent contradiction in HCMV inducing
NK cell migration: at this time point in the viral life cycle, infec-
tious progeny are being released, making it the perfect timing
for attracting and spreading through neutrophils. At the same
time, NK cells that are also attracted will only arrive at a late
time point in the life cycle, giving the previously mentioned viral
immune evasion mechanisms time to act and rendering NK cells
inefficient at this late stage.
Taking these results together, we suggest a model (Figure 7G)
in which HCMV-infected cells secrete vCXCL1 in order to attract
neutrophils. Neutrophils can serve as a ‘‘Trojan horse’’ carrier
of HCMV that facilitates the systemic spread of the virus
throughout the body (Figure 7G). NK cells are also attracted to
the infected cells. However, their migration is slower and less
efficient than neutrophils (Figure 7G). Thus, when NK cells finally
arrive at the site of infection, the virus is already distributed by
neutrophils and the infected cells can counterattack the NK cells
due to the numerous immune evasion mechanisms they have
developed (Wilkinson et al., 2008). The vCXCL1’s preferential
and selective targeting of neutrophils is an elegant example of
the highly evolved nature of HCMV subversion mechanisms as
it has been developed to walk a very thin line of harnessing the
immune cells to its own benefit without self-elimination.
EXPERIMENTAL PROCEDURES
The experiments in this paper were conducted under the oversight of the
Helsinki institutional review board.
Ethics Statement
NK cells and neutrophils that were used in this study were obtained from the
blood of healthy volunteers. The institutional Helsinki committee of Hadassah
approved the study (Helsinki number 0030-12-HMO). All subjects provided a
written informed consent.
NK and Neutrophil Isolation and Generation of IL-2-Activated Bulk
NK Cell Cultures
PBMCs were purified from heparinized blood by centrifugation on Lymphoprep
(StemCells Technologies). NK cells were isolated using the EasySep human NK
cell enrichment kit (StemCells Technologies). ActivatedNK lineswere generated
by culturing isolated NK cells together with irradiated feeder cells (2:53104 allo-
geneic PBMCs from two donors and 53103 RPMI-8866 cells in each well) and
20 mg/ml PHA (Roche). Both PBMCs and RPMI-8866 cells were irradiated in
6,000 rad prior to seeding in 96-well U-bottom plate. The cultures were main-
tained in DMEM:F-12 Nutrient Mix (70:30), 10% human serum (Sigma-Aldrich),
2 mM glutamine (Biological Industries [BI]), 1 mM sodium pyruvate (BI), 13
nonessential amino acids (BI), 100 U/ml penicillin (BI), 0.1 mg/ml streptomycin
(BI), and 500 U/ml rhIL-2 (PeproTech). NK cells were stained with anti-CD56-
phycoerythrin (BD Biosciences) and anti-CD3-allophycocyanin (BioLegend) to
confirm NK purity after isolation and following activation. Neutrophils isolationwas performed as previously described (Shpacovitch et al., 2011). Neutrophils
were stained with anti-CD16-FITC (BioLegend) and anti-CD66a/c/e-PE (Bio-
Legend). See also Supplemental Experimental Procedures.
Migration Assay and Recombinant Proteins
NKcells (0:53106; 100ml)wereplaced in theupperwell of a transwell filter (Corn-
ing; diameter, 6.5 mm; pore size, 5 mm; 24-well cells clusters). Filters were then
plated in bottomwells containing 600 ml migrationmedium (RPMI 1640with 1%
fetal calf serum [FCS]) supplemented with either rvCXCL1 (620-CM-025), rhIL8
(208-IL-050), rhFck (365-FR-025), or rhChemerin (2324-CM-025; obtained from
R&D Systems), as indicated in each figure. At least three wells were used for
each chemokine. After 3 hr of NK cell incubation, or 30min of neutrophil incuba-
tion, at 37C and 5% CO2, the upper chambers were removed and cells in the
bottomchamberwere collected andcountedusing a flowcytometer. For block-
ingofNKcellmigration, the cellswere incubatedwith the indicated recombinant
chemokines for1hrat 4Candthen loaded into theupperchamberof a transwell
plate. Blocking of neutrophil migration was performed for 10 min at 4C.
Competitive migration assays were performed with a mixture of NK cells and
neutrophils (0:13106 each in 100 ml total) at the upper well of a transwell filter.
Migration percentage was calculated by dividing the number of the migrating
cells by total input cells. Migration fold increase (FI) was calculated by dividing
the number of cells migrating in the presence of chemokines by thosemigrating
toward medium only (control). In the blocking experiments, migration percent-
age was calculated by setting the migration without blocking to 100% and
dividing the migration after blocking by this number.
Internalization Experiments
NK cells were incubated for 1 hr at 37C, whereas neutrophils were incubated
for 10 min at 37C, with the indicated recombinant chemokines, and then
stained with anti-CX3CR1 or anti-CXCR1 mAb.
Determination of vCXCL1 Concentration in the Supernatant of
Infected Cells
Freshly isolated neutrophils were incubated with increasing concentrations of
rvCXCL1 for 30 min at 37C, followed by staining with anti-CXCR2 mAb. MFI
of CXCR2 expression without blocking was set on 100%, and the percent-
ages of residual CXCR2 expression were calculated. The estimated levels of
vCXCL1 in the infected cell supernatants were calculated following infection
of HFF cells with WT HCMV and then incubation of neutrophils with superna-
tant collected from the infected cells 3 days postinfection. Staining with anti-
CXCR2 mAb was followed. Residual CXCR2 expression percentages were
calculated, and the levels of vCXCL1 in the supernatant were estimated.
HCMV Infections
The HCMV virus strains AD169-WT and theDUL146 (AD169 background) were
used in this study. Both viruses were propagated in HFF cells as previously
described (Brumeanu et al., 1996). HFF cells were infected at MOI of 1. Super-
natant was collected from the infected cells 72 hr postinfection and then used
for migration assays. See also Supplemental Experimental Procedures.
Statistical Analysis
Student’s t test was used to determine statistical significance. p value of less
than 0.05was considered significant. NS, not significant; *p < 0.05; **p < 0.005;
or ***p < 0.0005.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one figure, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.04.042.
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